MedImmune, LLC | AstraZeneca | Maryland | state | 2017 | $1,939,088 | | tax credit/rebate |
United Therapeutics | United Therapeutics | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2018 | $500,000 | | grant/loan hybrid program |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $44,733 | | training reimbursement |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2018 | $2,161,115 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2018 | $624,705 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2018 | $125,820 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2018 | $92,193 | | tax credit/rebate |
Emergent Biosolutions Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2018 | $86,355 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2018 | $74,842 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2018 | $68,671 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $38,025 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2018 | $34,340 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2018 | $21,507 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2018 | $10,120 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Maryland | state | 2018 | $9,085 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2019 | $1,475,043 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2019 | $1,338,392 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2019 | $641,295 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2019 | $172,893 | | tax credit/rebate |
United Therapeutics Corporation & Subs | United Therapeutics | Maryland | state | 2019 | $129,675 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2019 | $62,460 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Pfizer | Maryland | state | 2019 | $42,853 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2019 | $31,013 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2019 | $26,526 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2019 | $26,263 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Maryland | state | 2019 | $14,253 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2019 | $5,472 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2020 | $20,303 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2020 | $1,629,414 | | tax credit/rebate |
ELANCO US INC | Elanco Animal Health | Maryland | state | 2020 | $11,026 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2020 | $92,287 | | tax credit/rebate |
Emergent Biosolutions Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2020 | $37,509 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2020 | $40,117 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT LLC (AKA JRD LLC) | Johnson & Johnson | Maryland | state | 2020 | $16,769 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2020 | $181,829 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2020 | $791,333 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Maryland | state | 2020 | $3,909 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2020 | $26,857 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2020 | $48,205 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2020 | $65,492 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2020 | $41,168 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2021 | $22,214 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2021 | $1,461,100 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2021 | $41,307 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2021 | $55,509 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2021 | $31,602 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT | Johnson & Johnson | Maryland | state | 2021 | $29,953 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2021 | $603,374 | | tax credit/rebate |
MedImmune LLC | AstraZeneca | Maryland | state | 2021 | $794,270 | | tax credit/rebate |
Novo Nordisk Inc | Novo Holdings A/S | Maryland | state | 2021 | $3,194 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Pfizer | Maryland | state | 2021 | $29,497 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2021 | $100,088 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2021 | $49,887 | | tax credit/rebate |
Astrazeneca Pharmaceuticals, Lp | AstraZeneca | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Gilead Sciences, Inc. & Subsidiaries | Gilead Sciences | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Emergent Biosolutions Inc. And Subsidiaries | Emergent BioSolutions | Maryland | state | 2022 | $130,702 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2022 | $34,500 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2022 | $21,412 | | tax credit/rebate |
Janssen Research & Development | Johnson & Johnson | Maryland | state | 2022 | $19,167 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2019 | $500,000 | | grant/loan hybrid program |
Novavax, Inc. | Novavax Inc. | Maryland | local | 2020 | $1,000,000 | | grant/loan hybrid program |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $150,000 | | tax credit/rebate |
Sanofi-Aventis | Sanofi | Massachusetts | state | 2011 | $2,450,000 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $5,855,368 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $3,500,000 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,152,515 | | tax credit/rebate |
Foundation Medicine Inc. | Roche | Massachusetts | state | 2011 | $78,777 | | tax credit/rebate |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2011 | $996,605 | | tax credit/rebate |
Lightlab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2011 | $75,148 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $1,196,763 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,271,658 | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2011 | $30,041 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | Massachusetts | state | 2011 | $7,623 | | tax credit/rebate |
Codman and Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $66,093 | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $20,717 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2011 | $85,255 | | tax credit/rebate |
Abbott Bioresearch Center, inc. | Abbott Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | Massachusetts | state | 2006 | undisclosed | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
EMD Serono | Merck KGaA (EMD) | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
Epichem, Inc. | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
IDEXX Veterinary Services | IDEXX Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
PAREXEL International Corp. | Parexel International | Massachusetts | state | 1998 | undisclosed | | tax credit/rebate |
Parexel International, LLC | Parexel International | Massachusetts | state | 2011 | $29,879 | | tax credit/rebate |
Serono Labs | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
Shire Human Genetics Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $40,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $60,750 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2012 | $96,303 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $98,270 | | tax credit/rebate |